公开(公告)号：EP2579854A1

公开(公告)日：2013-04-17

申请号：EP11727080.1

申请日：2011-06-09

Applicant: Abbott Laboratories

Inventor： LIEPOLD, Bernd ,  JUNG, Tina ,  HOLIG, Peter ,  SCHROEDER, Rudolf ,  SEVER, Nancy E. ,  LAFOUNTAINE, Justin ,  SINCLAIR, Brent D. ,  GAO, Yi ,  WU, Jianwei ,  ERICKSON, Bryan K. ,  KULLMANN, Simon ,  WESTEDT, Ulrich ,  PAULI, Mirko ,  HEITERMANN, Tanja ,  KOENIG, Renato ,  THIEL, Madlen ,  WOEHRLE, Gerd

IPC: A61K9/14 ,  A61K9/16 ,  A61K9/20 ,  A61K31/00

CPC classification number: A61K31/4025 ,  A61K9/146 ,  A61K9/1617 ,  A61K9/1635 ,  A61K9/1694 ,  A61K9/2027 ,  A61K9/2054 ,  A61K31/00

Abstract: The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.

公开(公告)号：EP1855683A2

公开(公告)日：2007-11-21

申请号：EP06735552.9

申请日：2006-02-21

Applicant: ABBOTT LABORATORIES

Inventor： ROSENBERG, Jöerg ,  REINHOLD, Ulrich ,  LIEPOLD, Bernd ,  BERNDL, Gunther ,  BREITENBACH, Jörg ,  ALANI, Laman ,  GHOSH, Soumojeet

IPC: A61K31/513 ,  A61K31/426 ,  A61K9/20 ,  A61K9/28

CPC classification number: A61K9/1694 ,  A61K9/1617 ,  A61K9/1635 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/2031 ,  A61K9/204 ,  A61K9/2077 ,  A61K9/2095 ,  A61K9/2866 ,  A61K31/00 ,  A61K31/426 ,  A61K31/427 ,  A61K31/513 ,  A61K47/32 ,  A61K2300/00

Abstract: The present invention provides a pharmaceutical dosage formulation, and more particularly, to a pharmaceutical dosage formulation comprising an HIV protease inhibitor.